FDA Approves Medtronic's Deep Brain Stimulation for Parkinson's
From: Medical Design Technology - 02/18/2016

Medtronic plc announced US Food and Drug Administration (FDA) approval of
Medtronic Deep Brain Stimulation (DBS) Therapy for use in people with
Parkinson's disease of at least four years duration and with recent onset of
motor complications, or motor complications of longer-standing duration that
are not adequately controlled with medication. In 2002, the FDA initially
approved Medtronic DBS Therapy for use in patients with advanced Parkinson's
disease. Medtronic DBS has demonstrated improvement in motor complications,
quality of life, activities of daily living, and reduction in medication
usage in individuals with Parkinson's disease.

Read the entire article at:
http://www.mdtmag.com/news/2016/02/fda-approves-medtronics-deep-brain-stimulation-parkinsons